Similar articles for PMID: 16847063

Year	Number of Results
1999	2
2000	3
2002	2
2003	5
2004	2
2005	3
2006	5
2007	6
2008	14
2009	9
2010	6
2011	13
2012	12
2013	7
2014	7
2015	10
2016	5
2017	7
2018	14
2019	4
2020	7
2021	8
2022	12
2023	4
2024	0

1

Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ, Barbour R, Huang J, Kling K, Lee M, Diep L, Keim PS, Shen X, Chataway T, Schlossmacher MG, Seubert P, Schenk D, Sinha S, Gai WP, Chilcote TJ. Anderson JP, et al. J Biol Chem. 2006 Oct 6;281(40):29739-52. doi: 10.1074/jbc.M600933200. Epub 2006 Jul 17. J Biol Chem. 2006. PMID: 16847063 Free article.

2

α-synuclein phosphorylation and truncation are normal events in the adult human brain.

Muntané G, Ferrer I, Martinez-Vicente M. Muntané G, et al. Neuroscience. 2012 Jan 3;200:106-19. doi: 10.1016/j.neuroscience.2011.10.042. Epub 2011 Oct 29. Neuroscience. 2012. PMID: 22079575

3

Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions.

McFarland MA, Ellis CE, Markey SP, Nussbaum RL. McFarland MA, et al. Mol Cell Proteomics. 2008 Nov;7(11):2123-37. doi: 10.1074/mcp.M800116-MCP200. Epub 2008 Jul 9. Mol Cell Proteomics. 2008. PMID: 18614564 Free PMC article.

4

Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.

Walker DG, Lue LF, Adler CH, Shill HA, Caviness JN, Sabbagh MN, Akiyama H, Serrano GE, Sue LI, Beach TG; Arizona Parkinson Disease Consortium. Walker DG, et al. Exp Neurol. 2013 Feb;240:190-204. doi: 10.1016/j.expneurol.2012.11.020. Epub 2012 Nov 28. Exp Neurol. 2013. PMID: 23201181 Free PMC article.

5

Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's Disease.

Bhattacharjee P, Öhrfelt A, Lashley T, Blennow K, Brinkmalm A, Zetterberg H. Bhattacharjee P, et al. J Proteome Res. 2019 May 3;18(5):2109-2120. doi: 10.1021/acs.jproteome.8b00982. Epub 2019 Apr 15. J Proteome Res. 2019. PMID: 30943367

6

Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.

Klucken J, Ingelsson M, Shin Y, Irizarry MC, Hedley-Whyte ET, Frosch M, Growdon J, McLean P, Hyman BT. Klucken J, et al. Acta Neuropathol. 2006 Feb;111(2):101-8. doi: 10.1007/s00401-005-0027-7. Epub 2006 Feb 16. Acta Neuropathol. 2006. PMID: 16482476

7

Investigating the presence of doubly phosphorylated α-synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases.

Fayyad M, Erskine D, Majbour NK, Vaikath NN, Ghanem SS, Sudhakaran IP, Abdesselem H, Lamprokostopoulou A, Vekrellis K, Morris CM, Attems J, El-Agnaf OMA. Fayyad M, et al. Brain Pathol. 2020 Jul;30(4):831-843. doi: 10.1111/bpa.12845. Epub 2020 May 6. Brain Pathol. 2020. PMID: 32324926 Free PMC article.

8

Pathological biochemistry of alpha-synucleinopathy.

Iwatsubo T. Iwatsubo T. Neuropathology. 2007 Oct;27(5):474-8. doi: 10.1111/j.1440-1789.2007.00785.x. Neuropathology. 2007. PMID: 18018483 Retracted.

9

α-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration.

Beyer K, Ariza A. Beyer K, et al. Mol Neurobiol. 2013 Apr;47(2):509-24. doi: 10.1007/s12035-012-8330-5. Epub 2012 Aug 25. Mol Neurobiol. 2013. PMID: 22923347 Review.

10

Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.

Tofaris GK, Razzaq A, Ghetti B, Lilley KS, Spillantini MG. Tofaris GK, et al. J Biol Chem. 2003 Nov 7;278(45):44405-11. doi: 10.1074/jbc.M308041200. Epub 2003 Aug 15. J Biol Chem. 2003. PMID: 12923179 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

141 results

Results by year